Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis

Patient and physician perspectives on the impact and management of perennia l (PAR) and seasonal allergic rhinitis (SAR) were studied. In all, 2139 sub jects were questioned about their medical conditions, severity and frequenc y of symptoms and satisfaction with treatment. A group of general practitio ners (GPs) were also invited to discuss their experiences in the management of rhinitis. In this UK survey, allergic rhinitis was more common than ast hma, hypertension, skin rashes, eczema and diabetes. The prevalence of SAR and PAR was 15% and 2%, respectively; Sneezing and runny nose were the most common symptoms and GPs were the main contact for advice and treatment (54 % of patients). Symptoms were well-controlled in 32% of patients. Allergic rhinitis affected work, home and social life in 29%, 34% and 30% of patient s, respectively. The GPs considered PAR to be more difficult to treat than SAR, and GP and patient level of satisfaction in the treatment of PAR was l ow. This suggests that education of patients and physicians on the benefits of allergen avoidance, and the selective use of the highly effective thera pies available on prescription could improve the level of satisfaction with therapy. Adherence to current guidelines on the management of rhinitis cou ld lead to an effective, structured treatment plan for patients.